Skip to main content
BCBP
NASDAQ Finance

BCB Bancorp Discloses $31.5M in Q4 Impairments and Charge-Offs, Including Cannabis REO Write-Down

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Negative
Importance info
9
Price
$7.61
Mkt Cap
$131.107M
52W Low
$7.41
52W High
$12.26
52W Position info
2.7% above low
Off High info
38% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

BCBP is trading near its 52-week low of $7.41 (2.7% above the low) on light trading volume (0.1× avg).

Summary

BCB Bancorp announced significant pre-tax write-downs and net charge-offs totaling $31.5 million for Q4 2025, primarily related to a cannabis-related real estate property and its C&I loan portfolio.


Key Events · Legal and Risk Events · BCBP

  • Material REO Write-Down

    The company reported a $15.1 million pre-tax write-down on an isolated cannabis-related real estate owned (REO) property for the fourth quarter of 2025.

  • Additional Loan Charge-Offs

    An additional $16.4 million in net charge-offs were disclosed, primarily from the commercial and industrial (C&I) loan portfolio, with a single $6.4 million C&I loan being the largest contributor.

  • Significant Total Impact

    The combined write-downs and charge-offs amount to $31.5 million for the fourth quarter of 2025, a substantial figure relative to the company's size.

  • Management's Capital Assessment

    Management stated that the Bank's financial position provides sufficient capital to absorb these losses without any material effect on its operations.


Analysis · BCBP · Finance

BCB Bancorp's disclosure of $31.5 million in material impairments and charge-offs for Q4 2025 is a highly negative development. This substantial amount, representing a significant portion of the company's market capitalization, raises serious concerns about asset quality, underwriting standards, and potential future credit losses. While management asserts the Bank has sufficient capital to absorb these losses, the magnitude of the write-downs, particularly on a cannabis-related REO property and the C&I loan portfolio, warrants close scrutiny. Investors should prepare for potential stock price volatility and carefully review the full Q4 earnings report for further details and management's outlook on asset quality and capital adequacy.

At the time of this filing, BCBP was trading at $7.61 on NASDAQ in the Finance sector, with a market capitalization of approximately $131.1M. The 52-week trading range was $7.41 to $12.26. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BCBP - Latest Insights

BCBP
Jun 18, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.95
Real-time Price: $10.17 info
Change: -$0.780 (-7%) info
Market Cap: $176.062M info
BCBP
Jun 18, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $10.85
Real-time Price: $10.17 info
Change: -$0.680 (-6%) info
Market Cap: $176.062M info
BCBP
Jun 11, 2026, 4:19 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $10.95
Real-time Price: $10.17 info
Change: -$0.780 (-7%) info
Market Cap: $176.062M info
BCBP
Jun 03, 2026, 2:58 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.29
Real-time Price: $10.17 info
Change: -$1.12 (-10%) info
Market Cap: $176.062M info
BCBP
Jun 01, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.43
Real-time Price: $10.17 info
Change: -$0.260 (-2%) info
Market Cap: $176.062M info